Development and validation of RP-HPLC method for the determination of Darifenacin Hydrobromide in bulk drug and pharmaceutical dosage form

Authors

  • Ankit Acharya Department of Pharmaceutics, Sri Adichunchanagiri College of Pharmacy, B.G.Nagara-Karnataka
  • N.K. Satish Department of Pharmaceutical analysis, Sri Adichunchanagiri College of Pharmacy, B.G.Nagara-Karnataka
  • L. Manoj Department of Pharmaceutical analysis, Sri Adichunchanagiri College of Pharmacy, B.G.Nagara-Karnataka
  • Renukaradhya Chitti Department of Pharmacy-practice, Sri Adichunchanagiri College of Pharmacy, B.G.Nagara-Karnataka

DOI:

https://doi.org/10.3126/kuset.v13i1.21251

Keywords:

Darifenacin hydrobromide, RP-HPLC, Validation, Recovery

Abstract

The main objective of present study is to develop and validate a new, simple, precise and accurate RP-HPLC method for the determination of Darifenacin Hydrobromide (DFH) in bulk and pharmaceutical dosage forms. The separation and quantification of the drug was achieved on a RP C18 column (250×4.6mm, 5μm) using a mobile phase of acetonitrile: buffer (50:50), pH 3.0 ± 0.2 at a flow rate of 1 mL/min with detection of analyte at 287 nm. The separation was achieved with in 4.0 ± 0.3 min. The method showed good linearity in the range of 10-100 μg/mL. The intra and inter day RSD ranged from 0.20-0.58%. The recovery (mean ± SD) of low, medium and high concentrations were 98.50 ± 0.20, 100.27 ± 0.15 and 100.90 ± 0.09 respectively. The limit of detection and limit of quantification were 0.31 and 0.61 μg/mL, respectively. It can be concluded that the present method could be superior over the methods which were reported earlier. 

Kathmandu University Journal of Science, Engineering and Technology

Vol. 13, No. 1, 2017, Page: 36-44

 

Downloads

Download data is not yet available.
Abstract
535
PDF
669

Downloads

Published

2018-10-04

How to Cite

Acharya, A., Satish, N., Manoj, L., & Chitti, R. (2018). Development and validation of RP-HPLC method for the determination of Darifenacin Hydrobromide in bulk drug and pharmaceutical dosage form. Kathmandu University Journal of Science, Engineering and Technology, 13(1), 36–44. https://doi.org/10.3126/kuset.v13i1.21251

Issue

Vol. 13 No. 1 (2017)

Section

Original Research Articles

License

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.